APA (7th ed.) Citation

YL, W., M, H., Y, Y., XN, Y., M, T., L, P., . . . A, D. (2026). Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer. The New England journal of medicine. https://doi.org/10.1056/NEJMoa2602628

Chicago Style (17th ed.) Citation

YL, Wu, et al. "Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer." The New England Journal of Medicine 2026. https://doi.org/10.1056/NEJMoa2602628.

MLA (9th ed.) Citation

YL, Wu, et al. "Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer." The New England Journal of Medicine, 2026, https://doi.org/10.1056/NEJMoa2602628.